Skip to main content
Premium Trial:

Request an Annual Quote

UC Riverside Gets $600K NIH Grant to Support Big Data Research

NEW YORK (GenomeWeb) – The National Institutes of Health has awarded the University of California, Riverside $600,000 to support data-intensive research being conducted at the university, UCR announced on Thursday.

Specifically, the grant will go toward the purchase of a Big Data cluster with high-performance CPU resources and data storage space equal to about 5,000 laptops, UCR said, adding the grant would benefit more than 160 researchers from more than 15 departments and several colleges at the university.

In the grant's abstract contained in an NIH database, UCR researchers said that large-scale genomics and computational modeling approaches, such as next-generation sequencing and other high-throughput technologies, are routinely being used at the university in projects targeting neuroscience, cancer research, environmental health, wound healing, degenerative, and infectious diseases.

"Because these technologies output extremely large data sets, disk-based data storage required to process these 'Big Data' efficiently has become a major bottleneck to support the computational needs of NIH-funded biomedical research," the abstract said.

"With the new equipment grant from [the] NIH, [UCR's] compute facility will be able to at least quadruple its current compute resources, which should greatly help resolve our shortage of Big Data compute resources to support many new research programs," Thomas Girke, an associate professor of bioinformatics in the Department of Botany and Plant Sciences, and the principal investigator on the grant, said in a statement. Girke is also the director of UCR's central bioinformatics facility.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more